<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04468516</url>
  </required_header>
  <id_info>
    <org_study_id>10010563</org_study_id>
    <nct_id>NCT04468516</nct_id>
  </id_info>
  <brief_title>Treatment of Chronic Back Pain With Focused Vibroacoustic Stimulation</brief_title>
  <official_title>Treatment of Chronic Back Pain With Focused Vibroacoustic Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abdullah Mosabbir</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KKT International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wilfrid Laurier University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic back and neck pain is the most common chronic condition worldwide. Unfortunately, the
      current available treatment options are limited and largely unsuccessful, which is considered
      as one of the primary drivers for the high cost of back pain management. Systematic reviews
      show that the results of common treatments including pain medications, surgery, exercise and
      psychological therapies for back pain demonstrate inconsistent results and moderate
      improvement. Therefore, non-invasive adjunct therapies can be a useful addition to
      traditional back pain management.

      Focused vibroacoustic treatment for back and neck pain is a non-invasive procedure that
      applies low frequency sound waves to the spine (50Hz-110Hz), and has shown consistent and
      positive results in early clinical and animal studies. The goal of this project is to test
      vibroacoustic sound waves delivered to the spine in a double blind randomized controlled
      trial to demonstrate the efficacy of focused vibroacoustics in treating chronic back pain.

      Participants with back pain will be recruited and divided into a treatment and placebo group
      and will undergo treatment at a clinic over a one month period. Outcome measures will be
      collected before and after the intervention period. Placebo participants will be offered the
      full treatment without charge after the experiment is over.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel double blind randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>There are two groups (treatment and placebo). The treatment is to stimulate vibroacoustic waves at the spine. The placebo is to stimulate vibroacoustic waves at the trapezius muscle. Participants will not know which group they are in until the end. Outcome assessors are separate from the intervention administrator and are blinded. Care providers are separate and blinded. Investigators who supervise the study are blinded. Only treatment administrators and the post doctoral research manager are informed.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of Visual Analog Scale for Pain</measure>
    <time_frame>1 month</time_frame>
    <description>A scale which measures the intensity of pain. Scored from 0 to 100. 0 means no pain, 100 means maximum pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline of Roland Morris Disability Questionnaire</measure>
    <time_frame>1 month</time_frame>
    <description>Measures back pain disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in baseline of EuroQol (EQ5D-5L) Questionnaire</measure>
    <time_frame>1 month</time_frame>
    <description>Quality of Life Questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Neck Pain Disability Index</measure>
    <time_frame>1 month</time_frame>
    <description>Measures neck pain disability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Medication Dosage</measure>
    <time_frame>1 month</time_frame>
    <description>The assessor will ask what medications the participant is taking. They will record the drug and dosage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Shoulder and Pelvis tilt</measure>
    <time_frame>1 month</time_frame>
    <description>Measured via calipers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Leg length</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cervical range of motion</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Palpatory tenderness of the spine</measure>
    <time_frame>1 month</time_frame>
    <description>The assessor will count and record the number of tender regions along the spine.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention is applied to the C1 of the spine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention is applied in reduced intensity to the trapezius muscle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist period</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will have a 1 month waitlist period where no intervention takes place.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>KKT</intervention_name>
    <description>Vibroacoustic sound waves applied focally.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham KKT</intervention_name>
    <description>sham KKT</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of chronic low back pain with a disease duration of more than 3
             months (further diagnostic results were not required)

          -  Aged 18-75.

          -  Scored at least 4/10 in pain scale (VAS or Numerical)

          -  Written consent

        Exclusion Criteria:

          -  Acute back pain

          -  Protrusion or prolapse of 1 or more intervertebral discs with concurrent neurological
             symptoms

          -  Radicular pain

          -  Prior vertebral column surgery

          -  Infectious spondylopathy

          -  Low back pain caused by inflammatory, malignant, or autoimmune disease

          -  Congenital deformation of the spine (except for slight lordosis or scoliosis)

          -  Compression fracture caused by osteoporosis

          -  Spinal stenosis

          -  Spondylolysis or spondylolisthesis

          -  Severe abdominal distension

          -  Smokers (more than 3 cigarettes per day or a history of severe smoking)

          -  Alcohol drinkers &gt;7 glasses per week

          -  Previous spinal surgery

          -  Morbid Obesity

          -  Back pain from pregnancy

          -  Back pain from neurodegeneration

          -  Uncontrolled diabetics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Abdullah A Mosabbir, PhD</last_name>
    <phone>6477875430</phone>
    <email>amosabbir@research.baycrest.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Quincy J Almeida, PhD</last_name>
    <phone>519.884.0710</phone>
    <phone_ext>x2840</phone_ext>
    <email>qalmeida@wlu.ca</email>
  </overall_contact_backup>
  <reference>
    <citation>Desmoulin GT, Yasin NI, Chen DW. Spinal mechanisms of pain control. Clin J Pain. 2007 Sep;23(7):576-85.</citation>
    <PMID>17710007</PMID>
  </reference>
  <reference>
    <citation>Desmoulin GT, Hewitt CR, Hunter CJ. Disc strain and resulting positive mRNA expression from application of a noninvasive treatment. Spine (Phila Pa 1976). 2011 Jun 15;36(14):E921-8. doi: 10.1097/BRS.0b013e3181fd78b3.</citation>
    <PMID>21289569</PMID>
  </reference>
  <reference>
    <citation>Desmoulin GT, Reno CR, Hunter CJ. Free axial vibrations at 0 to 200 Hz positively affect extracellular matrix messenger ribonucleic acid expression in bovine nucleus pulposi. Spine (Phila Pa 1976). 2010 Jul 1;35(15):1437-44. doi: 10.1097/BRS.0b013e3181c2a8ec.</citation>
    <PMID>20386503</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 3, 2020</study_first_submitted>
  <study_first_submitted_qc>July 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wilfrid Laurier University</investigator_affiliation>
    <investigator_full_name>Abdullah Mosabbir</investigator_full_name>
    <investigator_title>Post Doctoral Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

